BCA101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCA101, covering 2025-08-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]